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Multitype violence exposures and adolescent
antiretroviral nonadherence in South Africa
Lucie Cluvera,b, Franziska Meincka,c, Elona Toskad,
F. Mark Orkina,e, Rebecca Hodesd and Lorraine Sherrf
Objectives: HIV-positive adolescents have low-ART adherence, with consequent
increased risks of mortality, morbidity, and viral resistance. Despite high rates of
violence against children in the Africa region, no known studies have tested impacts
on HIV-positive adolescents. We examine associations of ART adherence with adoles-
cent violence victimization by caregivers, teachers, peers, community members, and
healthcare providers.
Design andmethods: HIV-positive adolescents were interviewed (n¼1060), and clinic
biomarker data collected. We sampled all 10–19-year olds ever ART-initiated within 53
clinics in 180 South African communities (90.1% reached). Analyses examined asso-
ciations between nonadherence and nine violence types using sequential multivariate
logistic regressions. Interactive and additive effects were tested with regression and
marginal effects.
Results: Past-week self-reported ART nonadherence was 36%. Nonadherence corre-
lated strongly with virologic failure (OR 2.3, CI 1.4–3.8) and symptomatic pulmonary
tuberculosis (OR 1.49, CI 1.18–2.05). Four violence types were independently associ-
ated with nonadherence: physical abuse by caregivers (OR 1.5, CI 1.1–2.1); witnessing
domestic violence (OR 1.8, CI 1.22–2.66); teacher violence (OR 1.51, CI 1.16–1.96,)
and verbal victimization by healthcare staff (OR 2.15, CI 1.59–2.93). Past-week
nonadherence rose from 25% with no violence to 73.5% with four types of violence
exposure.
Conclusion: Violence exposures at home, school, and clinic are major and cumulating
risks for adolescent antiretroviral nonadherence. Prevention, mitigation, and protection
services may be essential for the health and survival of HIV-positive adolescents.
Copyright  2018 The Author(s). Published by Wolters Kluwer Health, Inc.
AIDS 2018, 32:975–983
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Introduction
Adolescents are the age group with the highest rates of
antiretroviral nonadherence, bringing elevated risks of
AIDS-related morbidity and mortality [1,2]. AIDS is the
most common cause of death amongst adolescents in
Africa [3]. Nonadherence can also lead to viral resistance
and greater risk of onwards HIV-transmission through
increased viral load [4].
There is an emerging evidence base on factors associated
with adolescent nonadherence to ART. Studies have
identified lower adherence amongst older adolescents and
those who are vertically infected [5]. Qualitative and
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quantitative reviews suggest risks related to ART
formulation and higher pill burden, depression and
behavioral problems, low family support, and parental
death [6–14]. Studies also suggest potential impacts
of economic factors such as poverty and food insecurity
[7,15].
The World Health Organization (WHO) Africa region,
home to 80% of HIV-positive adolescents also has the
world’s highest rates of violence against children and
adolescents [16]. Violence exposure takes place within a
range of settings and includes physical, psychological/
verbal, and sexual violence, [17]. Most adolescents live at
home, whereas some are exposed to abusive caregivers or
relatives and witness domestic violence between adults. In
addition, adolescence brings new independence and
exploration, with associated increased violence exposure
in community settings [18]. Studies also report physical
and verbal violence from teachers and clinic verbal
violence by healthcare providers, perhaps reflecting
the challenges faced by overburdened and resource-
constrained systems [19,20].
Two important recent studies show that exposure to
violence more broadly is associated with adolescent ART
nonadherence. In Malawi, Kim et al. [21] found that a
dichotomous variable of any exposure to sexual, physical
or household violence was strongly associated with
reduced adherence. In a US study (amongst 8–15-year
olds) a sum score of violence exposure (physical, sexual or
crime) was associated with nonadherence, unsuppressed
viral load and CD4þ% less than 25% [22]. Evidence from
other health behaviors shows that any form of violence
victimization during adolescence is associated with
negative health impacts, and that witnessing domestic
violence – especially within the home – may be equally
harmful [23,24]. In other non-HIV medical contexts,
abuse in the home has been shown to be associated with
medication nonadherence in children [25]. However, no
known studies have tested potential associations of
different types of violence with adolescent antiretroviral
nonadherence. In addition, increased severity, chronicity,
and exposure to multiple types of violence (polyvicti-
mization) show greater impacts on other health outcomes
such as increased mental health problems, substance
use, sexual risk behavior, HIV-infection and educational
delay [26–31]. There is a clear need to examine impacts
of different types and cumulative effects of violence
on adolescents living with HIV (ALHIV) in a high-
prevalence setting.
The current study tests potential associations of violence
exposure and antiretroviral nonadherence amongst
HIV-positive adolescents in South Africa. It examines
victimization and witnessing violence within home,
school, community, and clinic settings. First, we test
whether different types of violence are associated with
nonadherence, and if so which are most salient. Second,
we identify whether there are interactive or additive
effects of multiple victimization on adolescent antiretro-
viral nonadherence.
Methods
Procedures
We conducted a cross-sectional survey of ALHIV and
community controls in South Africa. The study took
place in the EasternCape, a provincewith the lowest per-
capita GDP nationally, and very limited social service
access [32]. Within a health sub-district constituting
urban, rural, and peri-urban settlements, all 53 facilities
providing adolescent antiretroviral therapy (ART;
hospitals, primary care clinics, and community health
centres) were visited and included in the study. In each
clinic, paper and computerized clinical files were
reviewed to identify every patient aged 10–19 who
had ever initiated ART, regardless of current healthcare
attendance. To prevent sampling bias towards those
attending healthcare, adolescents were not interviewed
in clinics, but were traced to 180 communities and
interviewed in their homes and schools. It was important
to avoid risk of stigma or identification of HIV-positive
status from participation in the research. Consequently,
the study was presented as focusing on general adolescent
use of health and social services, and as an additional
stigma avoidance strategy, we also interviewed
467 adolescents who were co-resident or living in
neighbouring households.
Ethical approval was given by IRBs at the Universities of
Cape Town (CSSR 2013/4) and Oxford (SSD/
CUREC2/12-21), the Provincial Departments of Health
and Education and participating health facilities. All
participants and their primary caregivers provided written
informed consent for interviews and accessing clinical
records. Consent procedures were also read aloud in case
of low literacy. No financial incentives were used, but
participants received a small gift pack, snacks, and a
certificate of participation. Confidentiality was main-
tained except in cases of disclosure of risk of harm.Where
participants reported on-going or prior abuse or violence,
referrals were made to relevant child protection, health
services, or police (n¼ 112 referrals). A registered child
protection social worker oversaw referrals and subsequent
follow-up.
Adolescents completed confidential 90-min tablet-based
questionnaires, designed in collaboration with a Teen
Advisory Group to be enjoyable and nonstigmatizing.
Measures were translated and back-translated into
Xhosa and English and completed in the language of
participants’ choice. Audio-CASI was used for sensitive
items. Researchers trained in working with vul-
nerable adolescents provided support for questionnaire
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completion, depending on adolescents’ literacy, and
cognitive needs. Research tools were prepiloted with 25
HIV-positive adolescents in the Eastern Cape. In order to
mitigate risk of social desirability bias, self-reported
nonadherencewas validated against two clinical outcomes
that may be associated with nonadherence: clinic-based
records of virologic failure [33] and a combination of
clinic records and self-reported symptomatic tuberculosis
(TB) [34]. The study was developed in collaboration with
the South African National Departments of Health,
Social Development and Basic Education and National
AIDS Council, UNICEF, PEPFAR-USAID, and NGOs
including Pediatric Adolescent Treatment for Africa.
Measures
ART nonadherence was measured using the standardized
self-report Patient Medication Adherence Questionnaire,
combined with measures developed in Botswana by
Lowenthal et al. [35,36]. After piloting, vignettes were
added to reduce social desirability bias, for example, ‘Even
if Lindiwe tries her best sometimes unexpected things get
in the way and prevent her from taking her pills. . . this is
not her fault.’ Past-week nonadherence was defined as
ART medication adherence below 95% over the
preceding 7 days (always including both a weekend
and weekdays) [37]. Two validation measures of self-
reported nonadherence were applied. Virologic failure was
measured using clinical records and defined as viral load
greater than 1000 copies/ml [38]. All viral load measures
taken in the year of interview and the prior year were
recorded. Concurrent symptomatic pulmonary TB was
measured as clinic report of TB diagnosis without
subsequent treatment in the past year or self-reported
WHO diagnostic criteria for symptomatic TB, validated
against sputum specimens [39,40]. To maximize precision
for case identification, we combined criteria for highest
positive predictive value (chronic cough and weight loss
with sensitivity 72.9%, specificity 85%, PPV 11.4) and
highest negative predictive value (NPV; any cough,
drenching night sweats, and weight loss with sensitivity
75%, specificity 82.4%, NPV 99.2) amongst HIV-positive
participants.
Violence exposure
Ten potential violence factors were measured and coded
as dichotomies of exposure/no exposure. Past-year physical
abuse victimization by caregivers at home past-year verbal
abuse victimization by caregivers at home and past-week
witnessing domestic violence between adults in the home were
measured using UNICEF Measures for National-level
Monitoring of Orphans and Vulnerable Children [41].
Contact sexual violence by any perpetrator was measured
using three items from the Juvenile Victimization
Questionnaire and defined as any lifetime contact sexual
abuse or forced sex [42]. Past-year physical violence from
teachers in school was measured as being hit by a teacher
‘sometimes’/‘always.’ Past-year physical violence from peers
and past-year verbal violence from peers were measured using
the Social and Health Assessment peer victimization scale
[43]. Past-year physical violence victimization in community
settings was measured as being physically attacked in the
community or being robbed and past-year witnessing of
violence in community settings was measured as any of past-
year witnessing of shootings or stabbings, using the Child
Exposure to Community Violence checklist [44]. Past-
year verbal violence in the clinic setting was measured as
adolescent self-report of being shouted at angrily by clinic
staff ‘sometimes’/‘always’.
Confounding variables
Nine potential confounders were identified using
quantitative and qualitative literature review of factors
associated with adherence amongst adult, pediatric, and
adolescent populations included socio-economic factors
of age, sex, urban/rural location, and living in formal or
informal housing, using items based on the 2011 Census
[45]. They also included family factors of maternal
orphanhood and paternal orphanhood, and HIV-related
factors of mode of infection (vertical/ horizontal), time
on ART treatment (in years), and travel time to clinical
care (dichotomized as >1 h) [46].
Analyses
Analyses were conducted in six stages in SPSS 21.0 and
STATA 14. First, associations of self-reported nonadher-
ence were tested in multivariate logistic regressions,
against validation measures of virologic failure and
symptomatic TB, controlling for potential confounders.
Second, known characteristics (sex, age, and location) of
excluded and included participants were compared to
check for potential differences. Violence variables were
excluded if numbers were too small for analysis. Third,
sociodemographic characteristics were reported and
potential associations between violence and ART
nonadherence were assessed following a sequential
regression approach recommended by Hosmer and
Lemeshow [47]. Three logistic regression models were
run: with all violence victimization factors and potential
confounders entered simultaneously, with all variables
significant at 0.1 or below, and with only variables
significant at 0.05 or below. Fourth, we tested all potential
two-way interactive effects between violence factors
significant in Stage 3, using logistic regression applying
Hochberg’s multiple hypothesis step-up method to
reduce false discovery rate. Fifth, we tested potential
moderation effects of sex and age on associations between
violence factors significant in Stage 3 and nonadherence,
using interaction terms in the final regression model.
Sixth, to test potential cumulative effects of multiple types
of violence exposure on ART nonadherence, marginal
effects models were run with all potential combinations of
significant violence factors and summarized with a
marginal effects model using a multiple-violence score
of 0–4 types of violence.
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Results
Of 1176 eligible ALHIV, 90.1% (n¼ 1060) were
interviewed together with community controls
(n¼ 467). 4.1% of ALHIV or their caregivers refused
participation, 0.9% were unable to participate because of
severe cognitive delay, 3.7% were untraceable and 1.2%
no longer lived in the study area.
Validating self-reported adherence
Self-reported nonadherence was 36% in the past week.
Only n¼ 412 (38.9%) of patient medical records included
a viral load measure taken within the past 2 years
(Table 1). In those, self-reported nonadherence was
significantly associated with virologic failure [odds ratio
(OR)¼ 2.32; CI 1.41–3.84, P¼ 0.001) independent of
age, sex, urban/rural location, formal/informal housing,
maternal orphanhood, paternal orphanhood, mode of
infection, time on ART treatment, and travel time to
clinic. In the full sample, self-reported nonadherence was
associated with increased rates of concurrent symptomatic
pulmonary TB (OR¼ 1.54, CI 1.07–2.22, P¼ 0.021),
independent of potential confounders.
Comparing included and excluded participants
Known factors of excluded participants (those who were
not able to be traced or interviewed) were identified from
clinic files as age, sex, and urban/rural location and
compared using z scores and chi-square tests. They
showed no significant differences from included partici-
pants on any variable.
Sociodemographic characteristics
HIV-positive participants had a mean age of 13.8, 55%
were girls and 22% lived in rural areas (Table 2). Nineteen
percent lived in informal housing and the remainder in
formal or traditional homes, 59% were paternal orphans,
48% were maternal orphans, and 67% were vertically
infected. Primary caregivers were 46% biological
mothers, 28% grandmothers, 15% aunts, 4% biological
fathers, 2% sisters, 1% uncles, 1% grandfathers, and 3%
other caregivers such as foster parents or carers in
children’s homes. Mean years on ARTwas 5.9 (median
5.0, range 0–19 years, IQR 8.0), and mean travel time to
clinical care was 45min (median 30min, range 0–3 h.
IQR 26min).
Levels of violence exposure were high (Table 2). Past-year
physical abuse from caregivers was 19.6%, verbal abuse
from caregivers was 18.6%, witnessing domestic violence
between adults at home was 11.8%, and sexual abuse was
5.2% (removed from subsequent analyses because of low
n). Physical violence by teachers was 41.2% and physical
violence by peers 45.7%, with verbal violence by peers at
46.6%. Past-year community violence victimization was
45.3% and witnessing of community violence 22.0%.
Verbal victimization by clinic healthcare staff was
experienced by 21.7% of adolescents.
Associations between violence exposure and
nonadherence
In the first model, five violence factors were excluded
with significance P> 0.1: verbal abuse by caregivers, peer
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Table 1. Multivariate logistic regression analyses testing associations between self-reported ART nonadherence, virologic failure, and
symptomatic pulmonary tuberculosis.
Virologic failure (N¼412)
Symptomatic pulmonary
tuberculosis (N¼1060)
OR, P-value 95% CI OR, P-value 95% CI
Age (years) 1.22M, 0.001 1.08–1.37 1.11M, 0.014 1.02–1.21
Female sex 0.71, 0.181 0.43–1.18 0.82, 0.277 0.56–1.18
Rural location 2.19M, 0.007 1.24–3.86 0.98, 0.919 0.63–1.53
Informal housing 0.96, 0.897 0.51–1.80 0.79, 0.361 0.48–1.30
Absent mother 1.11, 0.699 0.66–1.86 1.43, 0.068 0.97–2.10
Absent father 1.01, 0.976 0.60–1.70 0.87, 0.476 0.59–1.28
Vertical infection 2.72M, 0.026 1.13–6.57 1.65, 0.138 0.85–3.19
Time on ART (years) 0.92M, 0.026 0.86–0.99 0.95M, 0.047 0.90–1.00
Travel time to clinic more than 1 h 1.06, 0.874 0.49–2.29 1.22, 0.477 0.71–2.09
Past week ART nonadherence 2.32M, 0.001 1.41–3.84 1.54M, 0.021 1.07–2.22
MStatistically significant at P<0.05.
Table 2. Socio-demographic characteristics of HIVR adolescents in
this sample (nU1060).
Age (mean, SD, SE) 13.8, SD 2.84, SE 0.09
Female 55.9%
Rural location 21.6%
Informal housing 18.7%
Maternal orphanhood 48.4%
Paternal orphanhood 58.8%
Vertical infection 74.9%
Time on ART in years 6.29, SD 4.71, SE 0.15
Travel time to clinic more than 1 h 11.3%
Physical abuse 19.6%
Verbal abuse 18.6%
Domestic violence or conflict 11.8%
Teacher violence 41.2%
Peer physical violence 45.7%
Peer verbal violence 46.6%
Community violence victimization 45.3%
Witnessing community violence 22.0%
Clinic verbal violence 21.7%
physical violence, peer verbal violence, community
violence victimization, and witnessing community
violence (Table 3). Of the five remaining violence factors
retained in the second model, only four were significant
in the third and final model: physical abuse by caregivers,
witnessing domestic violence at home, violence from a
teacher at school, and verbal victimization from a clinic
staff member. All four types of violence were associated
with higher ART nonadherence, independent of each
other and of all covariates: physical abuse by caregivers
(OR 1.49, CI 1.18–2.05, P¼ 0.015); witnessing
domestic violence at home (OR 1.80, CI 1.22–2.66,
P¼ 0.003); violence from a teacher at school (OR 1.51,
CI 1.16–1.96, P¼ 0.002) and clinic verbal victimiza-
tion from a staff member (OR 2.15, CI 1.59–2.93,
P¼ 0.001).
No potential two-way and three-way interactions were
significant when P values were adjusted for multiple
hypothesis testing using Hochberg’s step-up method.
There were no significant moderation effects of sex or
age. Marginal effects models controlling for all factors
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Table 3. Multivariate logistic regression analyses testing associations between violence exposure and antiretroviral therapy nonadherence
among South African HIV-positive adolescents (nU1056a).
Model 1: all factors Model 2: all factors <0.1 Model 3: all factors <0.05
OR , P value 95% CI OR, P value 95% CI OR, P value 95% CI
Age 1.05, 0.199 0.98–1.12
Sex 1.12, 0.223 0.90–1.57
Vertical infection 1.09, 0.741 0.65–1.82
Time on treatment 0.99, 0.555 0.95–1.03
Rural location 139$, 0.054 0.99–1.03 1.40M, 0.033 1.03–1.91 1.44M, 0.020 1.06–1.97
Informal housing 0.81, 0.243 0.57–1.16
Travel to clinic more than 1 h 1.24, 0.313 0.82–1.89
Absent father 1.20, 0.224 0.90–1.60
Absent mother 0.79, 0.113 0.59–1.06
Physical abuse 1.55M, 0.012 1.10–2.18 1.42M, 0.034 1.03–1.99 1.49M, 0.015 1.18–2.05
Verbal abuse 1.32, 0.136 0.92–1.91 1.39$, 0.060 0.99–1.96
Domestic violence 1.61M, 0.024 1.07–2.44 1.74M, 0.007 1.17–2.59 1.80M, 0.003 1.22–2.66
Teacher violence 1.60M, 0.001 1.22–2.10 1.52M, 0.002 1.17–1.98 1.51M, 0.002 1.16, 1.96
Peer physical violence 1.14,0.452 0.82–1.58
Peer verbal violence 1.05, 0.748 0.77–1.44
Community violence victimization 0.77$, 0.083 0.57–1.04 0.85, 0.226 0.64–1.11
Witnessing community 0.97, 0.874 0.69–1.37
Violence
Clinic verbal violence 2.06M, 0.001 1.49–2.86 2.11M, 0.001 1.55–2.88 2.15M, 0.001 1.59–2.93
LR chi-square 87.09 70.11 65.67
CI, confidence interval; OR, odds ratio.
aThere were four missing cases.
MStatistically significant at P<0.05.
$Statistically significant at P<0.1.
Table 4. Cumulative effects of different types of violence in combination with each other on antiretroviral therapy adherence amongst South
African HIVR adolescents (nU1056).
ART nonadherence
Violence types and combinations Predicted % probability Lower CI Upper CI
No violence 25.61% 21.84 29.39
Physical abuse 33.85% 26.36 41.34
Teacher violence 34.17% 29.12 39.23
Domestic violence 38.24% 28.72 47.77
Clinic verbal violence 42.58% 35.11 50.05
Teacher violence and physical abuse 43.56% 35.55 51.57
Domestic violence and physical abuse 47.93% 36.16 59.71
Domestic violence and teacher violence 48.29% 37.95 58.63
Clinic verbal violence and physical abuse 52.43% 42.84 62.03
Clinic verbal violence and teacher violence 52.79% 44.58 61.00
Domestic violence and clinic verbal violence 57.15% 46.37 67.94
Domestic violence, teacher violence, and physical abuse 58.13% 46.86 69.40
Clinic verbal violence, teacher violence, and physical abuse 62.44% 53.48 71.40
Domestic, clinic verbal violence, caregiver physical abuse 66.48% 55.65 77.30
Domestic, clinic verbal violence, and teacher violence 66.79% 56.71 76.88
All types 74.94% 65.90 83.98
ART, antiretroviral therapy; CI, confidence interval.
significantly associated with ART nonadherence, show
additive increases in nonadherence with each different
combination of violence exposures (Table 4). This
showed a clear pattern of increasing risk of nonadherence
by additional violence exposures. Categorical Principal
Components Analysis (CATPCA) established that all four
violence variables loaded onto a single factor (Eigenvalue
1.5) accounting for 38.3% of the total variance. Loading
factors for all four violence predictors loaded between 0.3
and 0.65. A summative index of individual violence
variables (polyvictimization score) was computed (Fig. 1).
This showed a strongly graded relationship of significant
increases in nonadherence with each additional victimi-
zation. Nonadherence rose from 25.6% amongst adoles-
cents with no violence, to 36.5% with any one violence
victimization, 49.3% with any two victimization types,
62.2% with any three types, and 74.9% with all four
violence victimization types.
Discussion
Despite enormous progress in ART roll-out, nonadher-
ence remains a major impediment to the health and
survival of HIV-positive adolescents [48,49]. To date,
responses have focused on healthcare services, including
adolescent-friendly clinics, counseling, treatment literacy,
extended clinic opening hours, and peer support [50,51].
These have the potential to address important barriers to
retention in care.
But this study identifies an additional, structural-level
risk. Exposure to four types of violence was associated
with lower ART adherence, independent of each other,
and of socioeconomic, family, and HIV-related factors.
They included physical abuse from caregivers, witnessing
domestic violence between adults at home, physical
violence from teachers, and clinic verbal victimization by
healthcare providers.
Findings indicate that violence in community settings and
between peers, and verbal abuse from caregivers were not
associated with ART adherence. It may be that these are
perceived as part of a generally high-violence environ-
ment, and whilst they likely have other negative impacts
on adolescent development, they did not lead to inability
to take a lifesaving medication [16,52]. It is possible that
physical violence from caregivers and teachers, and clinic
verbal violence from healthcare providers evoke a sense of
betrayal amongst adolescents for whom they are hoped for
sources of care and support. Just as positive relationships
with adult role models may be protective for adolescent
health behavior, abusive relationships may be exception-
ally detrimental.
The violence type with the strongest individual associa-
tion with nonadherence was clinic victimization. Patient
care experiences may be a particularly important focus for
interventions, and qualitative studies of adult ART
patients in sub-Saharan Africa report negative provider–
patient interactions as a major barrier to adherence
[53,54]. Adolescents also report experiences of being
shouted at or treated harshly, whilst healthcare workers
report frustration and worry regarding their adolescent
patients [8,55]. A recent situational analysis of 218
healthcare facilities across sub-Saharan Africa found that
healthcare workers lacked training or protocols for
supporting HIV-positive adolescents, suggesting that
more targeted support may be essential [56].
This was primarily a young sample, with a mean age of 13
years and only 18% sexually active. As these adolescents
become older, it will be essential to also measure impacts
of intimate partner violence on ARTadherence. A recent
meta-analysis of intimate partner violence amongst HIV-
positive adult women (primarily in US-based studies)
found associations with lower ART use [25,57],
supported by quantitative and qualitative studies of adult
women in sub-Saharan Africa [58,59]. A study this year of
HIV-positive adolescents and young women in South
Africa found associations between intimate partner
violence and reduced medication adherence [60]. We
also need to understand if and how intimate partner
violence interacts with other types of violence and
whether this increases other risks, particularly for young
women.
It will be important to further examine the pathways by
which violence from different sources may impact
adolescent adherence. There is substantive evidence of
mental health problems associated with violence victimi-
zation, and this may lead to reduced self-esteem, future
orientation, and lowered motivation for adherence [24].
It is possible that high-violence home and school
environments are also less conducive to safe storage
and medication-taking, and may also contribute to
increased stigma and secrecy. Qualitative research suggests
that negative healthcare experiences can reduce trust in
980 AIDS 2018, Vol 32 No 8
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Fig. 1. Cumulative effects of violence exposure on predicted
probability of ART nonadherence among South African
HIVR adolescents.
medical treatment, and encourage care-seeking outside
of clinical settings [20]. Clinic verbal violence from
healthcare providers may alienate adolescents from
attending clinics, may trigger defiant behavior in terms
of nonadherence, and may inhibit them from disclosing
mental health distress or other risks for nonadherence.
This study has a number of limitations. First, all
associations are cross-sectional, thus no certainty regard-
ing causality can be held. In particular, shouting and
scolding by clinic staff may be both a cause of and a
response to nonadherence by adolescents. However,
measurement crossover for this association was reduced
by reporting periods – we measured past-week adher-
ence, whilst only a handful of adolescents had received
clinical care in the past week. The possibility of reverse
causality is also unlikely across all four types of violence
that were found to be associated with nonadherence.
Second, we did not measure intimate partner violence
experienced by adolescents, and rates of reported sexual
abuse within the HIV-positive sample were too small for
inclusion in analyses: these are important potential risk
factors that require further investigation.
Third, a strength of this study was that it was a real-world
sample of adolescents initiated on ART in government
healthcare services in a low-resource South African
province. We had overall high inclusion rates, and
community-tracing from all clinical files allowed inclu-
sion of adolescents regardless of healthcare retention.
However, 9% of ever-initiated adolescents were untrace-
able, had severe cognitive delay, or did not consent. These
may be important subgroups for risk of violence
victimization and nonadherence – in particular, there
is specific evidence that children with any form of
disability may be particularly vulnerable to violence [61–
63]. Finally, this study uses self-reported nonadherence,
which has the risk of under-reporting because of recall
and social desirability biases. However, reviews have
identified some unreliability in all methods of measuring
ART adherence [64,65]. This study found high correla-
tion between self-reported nonadherence, virological
suppression failure, and symptomatic TB, as found in
other multisite studies [66,67].
Despite limitations, this study has major implications for
adolescent HIV care. It is the first to examine associations
of multiple types of violence victimization to non-
adherence. It finds impacts of violence – both witnessing
and victimization – and strong and graded effects
of polyvictimization with increased nonadherence.
Amongst adolescents exposed to four types of violence,
only 25% were adherent in the past week, compared with
75% of nonvictimized adolescents.
Findings suggest that violence prevention and response
may be an essential, and insufficiently addressed,
component of adolescent HIV care. Fortunately, there
is an increasing evidence-base for effective violence
prevention programs for adolescents in high HIV-
prevalence countries. The Good Schools program has
been shown to reduce teacher and peer violence against
learners in Uganda, and the Parenting for Lifelong Health
programs show reductions in caregiver violence in South
Africa [68–71]. Also in Uganda, the SASA! program
reduced intimate partner violence between adults, and in
South Africa the PREPARE trial showed reduced IPV
victimization amongst school-going adolescents [72]
with further trials are underway [31,73,74]. There are
no known effective programs shown to reduce verbal
violence towards adolescents within clinical settings,
although reviews suggest that reducing workload and
providing patient-centred care skills may be helpful [75].
Integrating violence prevention and HIV treatment is a
complex challenge in resource-constrained settings. It
will be important to ensure that HIV-positive adolescents
access services for violence prevention and response,
without exposing families to dual stigma. However, new
initiatives such as kNOw Violence and the Global
Partnership to End Violence against Children’s INSPIRE
package provide important opportunities for advocacy,
evidence-building and multiagency collaboration
[17,76]. Sustainable Development Goal 17 promotes
integration between goals, and these findings demonstrate
the importance of ending violence against children (SDG
16) for the promotion of HIV healthcare (SDG 3). If we
do not rise to the challenge of addressing violence, the
goal of ending AIDS will remain out of reach.
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